OrganaBio Presentation: Partnering for Progress: Cell and Gene Therapy's Integrated Business Model 2.0
Thursday, May 30, 2024 01:15 PM - 01:30 PM
Exhibit Hall - Theatre B
Global Showcase Presentation
Presenter
This session explores how vertically integrated capabilities and data-driven, strategically placed operations facilitate economies at scale. From tissue sourcing, contract research and manufacturing, to supporting clinical trial management, OrganaBio’s business model is client-focused and includes purpose-built infrastructure specifically designed to support global drug developers throughout all stages of their therapeutic development lifecycles.
The power of integrated business models, strategic partnerships within CGT, and an end-to-end solution-based ecosystem can play a pivotal role in accelerating advancements and ensuring equitable access to these life-saving therapies.
- Priya Baraniak, PhD, Chief Business Officer; Co-Lead Process Development & Manufacturing; Laboratory Director, OrganaBio, USA
This session explores how vertically integrated capabilities and data-driven, strategically placed operations facilitate economies at scale. From tissue sourcing, contract research and manufacturing, to supporting clinical trial management, OrganaBio’s business model is client-focused and includes purpose-built infrastructure specifically designed to support global drug developers throughout all stages of their therapeutic development lifecycles.
The power of integrated business models, strategic partnerships within CGT, and an end-to-end solution-based ecosystem can play a pivotal role in accelerating advancements and ensuring equitable access to these life-saving therapies.
SPONSORED BY:
